INCB086550
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for INCB086550, covering 2025-03-13 to 2025-09-24. Get the full timeline:
Most recent: Clinical Trial Update: To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550 [Phase 1]